Insights

Gathering insights about annex…

Similar companies to annex

annex Tech Stack

annex uses 8 technology products and services including Varnish, Docker, Amazon Simple Email Service, and more. Explore annex's tech stack below.

Varnish
Caching
Docker
Containerization
Amazon Simple Email Service
Email
jQuery
Javascript Libraries
Platform.sh
Platform As A Service
C#
Programming Languages
Bootstrap
UI Frameworks
HTTP/3
Web & Portal Technology

Media & News

Annexon Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $86.25 Million
BRISBANE, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body, brain, and eye, today announced the closing of its previously announced underwritten public offering of 29,423,075 shares of its common stock, which includes the full exercise of the underwriters' option to purchase 4,326,922 additional shares of common stock, at a price to the public of $2.60 per share and, in lieu of shares of common stock to certain investors, pre-funded warrants to purchase 3,750,000 shares of common stock at a purchase price of $2.599 per share, which equals the public offering price per share of the common stock less the $0.001 exercise price per share of each pre-funded warrant.
Nov 14, 2025 | www.globenewswire.com
Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants
BRISBANE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body, brain, and eye, today announced the pricing of its previously announced underwritten public offering of 25,096,153 shares of its common stock at a price to the public of $2.60 per share and, in lieu of shares of common stock to certain investors, pre-funded warrants to purchase 3,750,000 shares of common stock at a purchase price of $2.599 per share, which equals the public offering price per share of the common stock less the $0.001 exercise price per share of each pre-funded warrant.
Nov 12, 2025 | www.globenewswire.com
Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
BRISBANE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (NASDAQ: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body, brain, and eye, today announced that it has commenced an underwritten public offering of $75 million of shares of its common stock or pre-funded warrants to purchase shares of its common stock in lieu thereof. All of the securities are being offered by Annexon. In addition, Annexon expects to grant the underwriters a 30-day option to purchase up to an additional $11.25 million of shares of its common stock. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the proposed offering.
Nov 12, 2025 | www.globenewswire.com
Annexon Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
Late-Stage Neuroinflammation Platform Advancing Global Registrational Programs in Guillain-Barré Syndrome ( GBS) and Geographic Atrophy (GA) Current Tanruprubart GBS Dossier On Track for MAA Filing in January 2026; Potential to Be the First Approved Targeted and Fast-Acting Therapy for the Treatment of GBS; Continued FDA Discussions Regarding Generalizability Package in Support of BLA Filing Topline ARCHER II Pivotal Data for Vonaprument in Dry AMD with GA on Track for Second Half of 2026; Potential to Be the First Approved Vision Sparing Therapy for the Treatment of Eight Million GA Patients Worldwide ANX1502 Cold Agglutinin Disease (CAD) Proof of Concept Study Ongoing with Expected 2026 Completion; Potential to Be the Only Oral C1s Inhibitor for the Treatment of Multiple Neuroinflammatory Autoimmune Diseases Strong Financial Position and Execution Extends Operations into 2027, Through Several Important Milestones, Including Tanruprubart Global GBS Filings, Vonaprument Topline GA Phase 3 Data, and ANX1502 Autoimmune Proof of Concept Data BRISBANE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated neuroinflammatory diseases of the body, brain, and eye, today highlighted portfolio progress, announced key anticipated milestones and reported third quarter 2025 financial results.
Nov 10, 2025 | www.globenewswire.com
Annexon, Inc. (ANNX) Presents at Cantor Global Healthcare Conference 2025 Transcript
Annexon, Inc. (NASDAQ:ANNX ) Cantor Global Healthcare Conference 2025 September 4, 2025 8:00 AM EDT Company Participants Douglas Love - CEO, President & Director Conference Call Participants Pete Stavropoulos - Cantor Fitzgerald & Co., Research Division Presentation Pete Stavropoulos Biotech Analyst So welcome to the Cantor Global Healthcare Conference. I'm Pete Stavropoulos, biotech analyst with Cantor.
Sep 05, 2025 | seekingalpha.com

annex's Email Address Formats

annex uses at least 1 format(s):

annex Email Formats	Example	Percentage
First@annex.com.au	John@annex.com.au	50%
First.Last@annex.com.au	John.Doe@annex.com.au	43%
First.Middle@annex.com.au	John.Michael@annex.com.au	3%
Fir.Last@annex.com.au	Joh.Doe@annex.com.au	4%

Frequently Asked Questions

Where is annex's headquarters located?

annex's main headquarters is located at Level 8, 12 Moore St, Suite 2 Canberra, Australian Capital Territory 2601, AU. The company has employees across 4 continents, including OceaniaNorth AmericaAsia.

What is annex's stock symbol?

annex is a publicly traded company; the company's stock symbol is ANNX.

What is annex's official website and social media links?

annex's official website is annex.com.au and has social profiles on LinkedIn.

What is annex's NAICS code?

annex's NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does annex have currently?

As of October 2025, annex has approximately 39 employees across 4 continents, including OceaniaNorth AmericaAsia. Key team members include Principal, Co-Founder: S. N.Managing Director: L. G.Director: E. D. C.. Explore annex's employee directory with LeadIQ.

What industry does annex belong to?

annex operates in the IT Services and IT Consulting industry.

What technology does annex use?

annex's tech stack includes VarnishDockerAmazon Simple Email ServicejQueryPlatform.shC#BootstrapHTTP/3.

What is annex's email format?

annex's email format typically follows the pattern of First@annex.com.au. Find more annex email formats with LeadIQ.

When was annex founded?

annex was founded in 2016.

annex

Q: What is annex's official website and social media links?

annex's official website is annex.com.au. annex has social profiles on LinkedIn.

Q: How many employees does annex have currently?

annex has approximately 39 employees.

Q: What technology does annex use?

annex's tech stack includes Amazon Web Services, Cloudflare, Bootstrap, Selenium, Postman.

IT Services and IT ConsultingAustralia11-50 Employees

We are a digital agency who will work with you to create meaningful change through thoughtful design and smart technologies.

We design and engineer digital products and services through an agile and collaborative process, delivering services, websites, apps, intranets, and Design Systems that make your users' lives better – and your job easier – with usability front-of-mind.

Company Overview

Headquarters: Level 8, 12 Moore St, Suite 2 Canberra, Australian Capital Territory 2601, AU
Website: annex.com.au
Stock Symbol: ANNX
NAICS Code: 5415 - Computer Systems Design and Related Services
Founded: 2016
Employees: 11-50

Media & News

Funding & Financials

$1M$10M
annex's revenue is estimated to be in the range of $1M$10M

Funding & Financials

$1M$10M
annex's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to annex

Bindery

Eight VFX

Optimus

Union Editorial

Bottle Rocket Media

Nice Shoes

The Colonie

Therapy Studios

Stept Studios

annex Tech Stack

Media & News

Annexon Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $86.25 Million

Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants

Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Annexon Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones

Annexon, Inc. (ANNX) Presents at Cantor Global Healthcare Conference 2025 Transcript

annex's Email Address Formats

Frequently Asked Questions

Where is annex's headquarters located?

What is annex's stock symbol?

What is annex's official website and social media links?

What is annex's NAICS code?

How many employees does annex have currently?

What industry does annex belong to?

What technology does annex use?

What is annex's email format?

When was annex founded?

annex

Company Overview

Media & News

Annexon Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $86.25 Million

Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants

Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?